Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis.
Kang YM, Park YE, Park W, Choe JY, Cho CS, Shim SC, Bae SC, Suh CH, Cha HS, Koh EM, Song YW, Yoo B, Lee SS, Park MC, Lee SH, Arendt C, Koetse W, Lee SK.
Kang YM, et al. Among authors: koh em.
Korean J Intern Med. 2018 Nov;33(6):1224-1233. doi: 10.3904/kjim.2016.213. Epub 2018 Jan 5.
Korean J Intern Med. 2018.
PMID: 29294598
Free PMC article.
Clinical Trial.